Search

Objective:   Atrial arrhythmias represent significant morbidity and risk for mortality in Fontan patients. In a randomized trial involving patients undergoing a lateral tunnel Fontan between 1999 and 2001, Collins et al. investigated the safety and efficacy of a surgical atrial incision aimed at decreasing the incidence of intraatrial reentrant tachycardia (IART). The purpose of this study was to report the late follow-up of the aforementioned trial., Design:   All surviving patients previously enrolled in the randomized trial were eligible for this follow-up study. Patients' legal guardians were contacted for informed consent and data were obtained form a retrospective chart review., Results:   Of the 39 eligible patients, 29 were recruited: 15 in the intervention and 14 in the control groups. The median follow was 9.0 (1.2) years for the intervention group and 9.3 (1.1) years for the control group (P= .86). At most recent follow-up, there was no statistically significant difference in the demographic, echocardiographic, and electrophysiological data between the two groups. There was no late incidence of the primary outcome, IART. There were nine cases of late-onset sinus node dysfunction (SND): 5/15 in the intervention and 4/14 in the control groups (P= .99). There was only one late pacemaker implantation for early post-op SND., Conclusion:   At late follow-up 9 years post-Fontan, IART had not occurred in either group. There was no evidence of late-onset complications related to the interventional atrial incision. Further follow-up is warranted for this cohort., (© 2012 Wiley Periodicals, Inc.)

Background: Atrial pacing is indicated for sinus node dysfunction (SND) after Fontan surgery; preferred lead implantation technique is debated. We compare outcomes of transvenous (TV) and epicardial (Epi) atrial lead implants in this population., Methods: Retrospective review of Fontan patients undergoing atrial lead implant between 1992 and 2007. Demographics, lead performance data, and outcomes were analyzed., Results: 78 patients had 90 leads implanted: 25 via TV route and 65 via Epi route. Median follow-up was 1.6 years (TV) and 3.6 years (Epi). TV leads were implanted in older patients (23.1 vs 9.3 years, P < 0.001) and at longer intervals after Fontan (15.2 vs 4.9 years, P < 0.001). Pacing indication for most TV leads was SND, while Epi leads were also indicated for atrioventricular block. Acute complication rates were similar (8% TV vs 19% Epi, P = 0.23), but median hospital stay was shorter for TV (2 vs 5 days, P = 0.03). Thrombus was observed in five patients (two in TV; three in Epi), but no thromboembolic events were observed. Mean lead survival was similar (TV 9.9 vs Epi 7.8 years, P = NS). Energy threshold was lower at implant for TV leads (0.9 vs 2.2 microJ, P = 0.049), but similar at follow-up (1.2 vs 2.6 microJ, P = 0.35). Atrial sensing was unchanged over time for TV (2.2 to 2.1 mV, P = NS), but decreased for Epi (3.3 to 2.5 mV, P = 0.02)., Conclusions: Compared to epicardial leads, transvenous atrial pacing leads may be placed in Fontan patients with lower procedural morbidity and equivalent expectation of lead performance and longevity.